Lundbeck企业 Annual report 2005英文学习资料.pdf

Lundbeck企业 Annual report 2005英文学习资料.pdf

ID:51997381

大小:1.96 MB

页数:108页

时间:2020-03-21

Lundbeck企业 Annual report 2005英文学习资料.pdf_第1页
Lundbeck企业 Annual report 2005英文学习资料.pdf_第2页
Lundbeck企业 Annual report 2005英文学习资料.pdf_第3页
Lundbeck企业 Annual report 2005英文学习资料.pdf_第4页
Lundbeck企业 Annual report 2005英文学习资料.pdf_第5页
资源描述:

《Lundbeck企业 Annual report 2005英文学习资料.pdf》由会员上传分享,免费在线阅读,更多相关内容在应用文档-天天文库

1、ANNUALREPORT2005Weimprovethequalityoflifeforthosesufferingfrompsychiatricandneurologicaldisorders2005INBRIEFFinancialratiosRevenuebygeography,DKKmDKKmRevenue9,0702005GrowthShare*Researchanddevelopment1,782Europa5,07611%55%Profitfromoperations2,170USA2,618-23%29%Netprofitfortheyear1,5

2、89InternationalMarkets1,1433%13%Otherrevenue232-63%3%DKKpershareEarningspershare(EPS)7.11*ShareofconsolidatedrevenueDividendpershare2.10�������������������������������100%focusonCNS��Lundbeckistheonlyfullyintegratedpharmaceuticalcompanyinthe���������worldfocusingexclusivelyontreating

3、diseasesofthecentralnervous�����������������������system–CNS.Duringthepastfouryears,Lundbeckhaslaunchedfour������������������������������newandinnovativepharmaceuticals.�������������SalesoftheGroup’snewpharmaceuticals–Cipralex®/Lexapro®,Ebixa®andAzilect®represented69%ofrevenuein2005.

4、Atthebeginningof2006,LundbecklaunchedSerdolect®.������Lundbeck’spharmaceuticalsCipralex®/Lexapro®(escitalopram)fortheEbixa®(memantine)forthetreatmentofphreniabothreceivedmarketingapprovaltreatmentofdepressionandanxietyhasAlzheimer’sdiseasewaslaunchedin2002.during2005.Azilect®waslaunc

5、hedinthebeenapprovedin82countries,andattheMemantinewasthesecond-mostprescribedfirstcountryinEuropeinJune,whileendof2005itwasthesecond-mostpre-pharmaceuticalforthetreatmentofAlzheimer’sSerdolect®waslaunchedinthefirstmarketscribedantidepressantintheUSmarket,diseaseinEuropein2005.inEuro

6、peatthebeginningof2006.whilethemarketshareheldbyCipralex®inEuropeattheendof2005hadclimbedtoAzilect®(rasagiline)forthetreatmentofSeealistofLundbeck’spharmaceuticalson9.9%ofthetotalantidepressantsmarketinParkinson’sdiseaseandSerdolect®page26.termsofvalue.(sertindole)forthetreatmentofsc

7、hizo-DevelopmentpipelineIn2005,Lundbeckpursuedactivitiesforthe•SchizophreniaandpsychoticdisordersLundbeckintendstomaintainitshighlevelclinicaldevelopmentofpharmaceuticalsto(bifeprunox,Lu31-130)ofR&Dinvestments.treat:•Parkinson’sdisease(CEP1347-discontinued)Seethesectiononthedevelopme

8、ntofnew•Depr

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。